BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yousefpouran S, Mostafaei S, Manesh PV, Iranifar E, Bokharaei-salim F, Nahand JS, Mirzaei H, Taran M, Babaei F, Sayad B, Moghoofei M. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker. Microbial Pathogenesis 2020;147:104355. [DOI: 10.1016/j.micpath.2020.104355] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Formosa A, Turgeon P, dos Santos CC. Role of miRNA dysregulation in sepsis. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00527-z] [Reference Citation Analysis]
2 Joshi N, Chandane Tak M, Mukherjee A. The involvement of microRNAs in HCV and HIV infection. Ther Adv Vaccines Immunother 2022;10:25151355221106104. [PMID: 35832725 DOI: 10.1177/25151355221106104] [Reference Citation Analysis]
3 Erfanparast L, Taghizadieh M, Shekarchi AA. Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions. Front Oncol 2022;12:914593. [DOI: 10.3389/fonc.2022.914593] [Reference Citation Analysis]
4 Abbasi-Kolli M, Sadri Nahand J, Kiani SJ, Khanaliha K, Khatami A, Taghizadieh M, Torkamani AR, Babakhaniyan K, Bokharaei-Salim F. The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease. Braz J Infect Dis 2022;26:102354. [PMID: 35500644 DOI: 10.1016/j.bjid.2022.102354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Elzarki AF, Nandula SR, Awal H, Simon GL, Sen S. Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells. Stem Cell Res Ther 2022;13:103. [PMID: 35255964 DOI: 10.1186/s13287-022-02775-6] [Reference Citation Analysis]
6 Letafati A, Najafi S, Mottahedi M, Karimzadeh M, Shahini A, Garousi S, Abbasi-Kolli M, Sadri Nahand J, Tamehri Zadeh SS, Hamblin MR, Rahimian N, Taghizadieh M, Mirzaei H. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cell Mol Biol Lett 2022;27:14. [PMID: 35164678 DOI: 10.1186/s11658-022-00317-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
7 Chen H, Yang A, Wu C, Lin J, Wang X, Peng M, Li D, Zhang T, Zhao Q, He X. Identification of a detection panel for post-transplant virus infection through integrated analysis of non-coding RNAs in peripheral blood. Artif Cells Nanomed Biotechnol 2021;49:691-8. [PMID: 34882040 DOI: 10.1080/21691401.2021.2011304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Maleki B, Alani B, Tamehri Zadeh SS, Saadat S, Rajabi A, Ayoubzadeh SMJ, Verdi J, Farrokhian A, Ghanbarian H, Noureddini M, Nejati M. MicroRNAs and exosomes: Cardiac stem cells in heart diseases. Pathol Res Pract 2021;229:153701. [PMID: 34872024 DOI: 10.1016/j.prp.2021.153701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Valle-Millares D, Brochado-Kith Ó, Martín-Carbonero L, Domínguez-Domínguez L, Ryan P, De Los Santos I, De la Fuente S, Castro JM, Lagarde M, Cuevas G, Mayoral-Muñoz M, Matarranz M, Díez V, Gómez-Sanz A, Martínez-Román P, Crespo-Bermejo C, Palladino C, Muñoz-Muñoz M, Jiménez-Sousa MA, Resino S, Briz V, Fernández-Rodríguez A, On Behalf Of Multidisciplinary Group Of Viral Coinfection Hiv/Hepatitis Covihep. Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients. Biomedicines 2021;9:1627. [PMID: 34829855 DOI: 10.3390/biomedicines9111627] [Reference Citation Analysis]
10 Leo CG, Mincarone P, Tumolo MR, Panico A, Guido M, Zizza A, Guarino R, De Santis G, Sedile R, Sabina S. MiRNA expression profiling in HIV pathogenesis, disease progression and response to treatment: a systematic review. Epigenomics 2021;13:1653-71. [PMID: 34693727 DOI: 10.2217/epi-2021-0237] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Donyavi T, Bokharaei-salim F, Baghi HB, Khanaliha K, Alaei Janat-makan M, Karimi B, Sadri Nahand J, Mirzaei H, Khatami A, Garshasbi S, Khoshmirsafa M, Jalal Kiani S. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. International Immunopharmacology 2021;97:107641. [DOI: 10.1016/j.intimp.2021.107641] [Reference Citation Analysis]
12 Jafari SH, Rabiei N, Taghizadieh M, Mirazimi SMA, Kowsari H, Farzin MA, Razaghi Bahabadi Z, Rezaei S, Mohammadi AH, Alirezaei Z, Dashti F, Nejati M. Joint application of biochemical markers and imaging techniques in the accurate and early detection of glioblastoma. Pathol Res Pract 2021;224:153528. [PMID: 34171601 DOI: 10.1016/j.prp.2021.153528] [Reference Citation Analysis]
13 Karimi-Maleh H, Orooji Y, Karimi F, Alizadeh M, Baghayeri M, Rouhi J, Tajik S, Beitollahi H, Agarwal S, Gupta VK, Rajendran S, Ayati A, Fu L, Sanati AL, Tanhaei B, Sen F, Shabani-Nooshabadi M, Asrami PN, Al-Othman A. A critical review on the use of potentiometric based biosensors for biomarkers detection. Biosens Bioelectron 2021;184:113252. [PMID: 33895688 DOI: 10.1016/j.bios.2021.113252] [Cited by in Crossref: 47] [Cited by in F6Publishing: 168] [Article Influence: 47.0] [Reference Citation Analysis]
14 Donyavi T, Bokharaei-Salim F, Baghi HB, Khanaliha K, Alaei Janat-Makan M, Karimi B, Sadri Nahand J, Mirzaei H, Khatami A, Garshasbi S, Khoshmirsafa M, Jalal Kiani S. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int Immunopharmacol 2021;97:107641. [PMID: 33895478 DOI: 10.1016/j.intimp.2021.107641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 Nie Y, Deng X, Lan Y, Li L, Li F, Hu F. Comparison and Correlation of Genetic Variability of the HBV Pre-S Region in HIV/HBV Co-Infected Patients: Quasispecies Perspective. Infect Drug Resist 2020;13:4327-34. [PMID: 33293836 DOI: 10.2147/IDR.S278415] [Reference Citation Analysis]
16 Mirzaei H, Hamblin MR. Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect. Mol Ther Oncolytics 2020;19:218-39. [PMID: 33251334 DOI: 10.1016/j.omto.2020.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
17 Cheng ST, Hu JL, Ren JH, Yu HB, Zhong S, Wai Wong VK, Kwan Law BY, Chen WX, Xu HM, Zhang ZZ, Cai XF, Hu Y, Zhang WL, Long QX, Ren F, Zhou HZ, Huang AL, Chen J. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx. J Hepatol. 2021;74:522-534. [PMID: 32987030 DOI: 10.1016/j.jhep.2020.09.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]